|
|

Title: Method for producing dispersible sterol and
stanol compounds
United States Patent: 6,242,001
Inventors: Bruce; Richard D. (Rydal, PA); Burruano; Brid
(King of Prussia, PA); Hoy; Michael R. (Sellersville, PA); Paquette;
Nicholas R. (Danbury, CT)
Assignee: McNeil-PPC, Inc. ()
Appl. No.: 200623
Filed: November 30, 1998
Abstract
A method for preparing sterol/stanol and sterol/stanol ester
compositions with improved dispersibility is provided by co-melting the
sterol/stanol and/or sterol/stanol ester with highly branched hydrocarbons
and then grinding the resulting product. A method for preparing the
compounds is also disclosed. The ground compound is suitable for
formulating into orally administered products suitable for control of
blood serum cholesterol.
DETAILED DESCRIPTION OF THE INVENTION
Sterols/stanols are typically derived from agricultural
sources, such as corn, soy-based, and pine tree mixtures, and as such are
commonly referred to as sterols. The present invention also contemplates
esters of sterols/stanols through the reaction of the stanol/sterol with
the suitable acid. Suitable acids include saturated, unsaturated and
polyunsaturated acids. Suitable acids include but not limited to stearic,
butyric, lauric, palmitic, oleic, linoleic, linolenic, docohexanoic acid
and the like. Suitable methods for preparing these esters are well known
in the art, see for example, U.S. Pat. Nos. 5,502,045, 5,723,747, the
contents of which are incorporated herein by reference. The present
invention also includes stanols, the reduction product of sterol and
hydrogen, this reaction is well known to those with skill in the art.
The present invention also employs a food grade acceptable hydrocarbon,
preferably a branched hydrocarbon. As used throughout this specification,
food grade acceptable is defined as a material that is appropriate to be
incorporated into and consumed in a food by humans. The present invention
also includes food grade acceptable salts of these compounds.
As used throughout this invention the hydrocarbon disrupters are
understood to be a compound which contains primarily carbon and hydrogen
atoms and preferably contains at least 3 branched units in the compound.
Other atoms including but not limited to oxygen, nitrogen and sulfur may
also be included in the highly branched hydrocarbon. As used in this
specification, branched is understood to mean a hydrocarbon chain having a
length of at least two carbon atoms, preferably three or more and more
preferably 4 or more carbon atoms in length that are pendent from the
major backbone of the molecule.
Among the highly branched hydrocarbons suitable for use in the invention
include docusate sodium; blends of polyglocolized glycerides consisting of
mono-, di, and tri glycerides and of mono-, and di-fatty esters of
polyethylene glycol commercially available as Gelucire 44/14; Gelucire
50/13 (both from Gattefosse Corp.); acetylated monoglycerides,
commercially available as Myvacet 600 (Eastman Fine Chemicals); polyoxyl
40 hydrogenated castor oil commercially available as Cremopor RH40 (BASF
Corp.); polyoxyethylene 20 sorbitan monopalmitate available commercially
as TWEEN 40; and SPAN 80 (both from ICI Chemicals & Polymers of
America).
Linear polymeric materials, such as polyethylene glycol, polyoxyethylene,
polyoxypropylene or poloxamer, a nonionic polyoxyethylene-polyoxypropylene
co-polymer commercially available from BASF Corp., while not branched also
produce the disruption effect due to the variations in chain length
present in these materials.
The hydrocarbon is typically incorporated as a solid at a level of from
about 0.1 to about 50; preferably from about 0.4 to about 10; and most
preferably from about 0.5 to about 0.8 weight percent in the solid.
The hydrocarbon is added to the sterols/stanols typically by co-melting
the materials to a single-phase molten solution result. It is then
preferable to cool and grind the resulting mixture so as to have a more
easily handled particle size. Typical particle sizes are from about 10 to
about 150 microns, preferably from about 25 to about 75 microns. Suitable
methods include pulverizing, rotary hammermill, air milling and the like
of which air milling is most preferred. Smaller particles sizes are
preferred in that the resulting .beta.-sitosterol product is more readily
exposed to bile salts in the digestive tract.
A preferred method of determining whether the proper level of hydrocarbon
has been added to the sterol is to employ differential scanning
calorimetry (DSC). This technique measures the heat flow in the sample as
a function of temperature. The incorporation of the highly branched
hydrocarbon in the sterols/stanols reduces the crystallinity of the solid,
which results in improved water dispersibility. When using DSC, sufficient
crystal lattice disruption is known when the heat of fusion of the sterol/phytostanol
peak drops to less than about 2, and more preferably less than about 1
Joule/gram, signifying a significant loss of crystal lattice energy. It is
this low lattice energy which causes a huge increase in wetting ability of
sterol/stanol comelts with lattice-disrupting materials claimed in this
invention.
Another technique for measuring the crystallinity of the solid matrix is
to measure the time in which a ground powdered sample of the solid takes
to disperse in unstirred water. When an appropriate amount of the
appropriate hydrocarbon material has been added, the solid solution will
disperse in fifty milliliters of water in less than about 60 seconds,
preferably in less than about 45 seconds and most preferably less than
about 30 seconds. Agitation, including mild agitation such as a stirring
bar, can be employed to enhance the dissolution of the solid solution in
water.
Yet another method to determine whether the desired level of hydrocarbon
has been added to the sterol/stanol, is to measure the turbidity of the
solution after 100 milligrams of the ground sterol/stanol/hydrocarbon are
added to water. The greater turbidity value, the more effectively the
solid solution is able to be dispersed in water. Mixtures of sterol/stanol
and hydrocarbon with higher turbidty values are believed to provide a more
effective in reducing cholesterol when consumed. Preferred turbidity
levels are greater than about 1500, preferably greater than 2000 and most
preferably greater than 3000 Nephelometric Turbidity Units (NTU). As used
herein turbidity is understood to be the same as defined by the United
States Pharmacopeia, 15th Edition, the light scattering effect
of suspended particles and turbidity as the measure of the decrease in the
incident beam intensity per unit length of a given suspension. The range
of turbidty values is from 0 to 20,000 NTU. As a point of reference the
turbidity of water is zero. The turbidity of the samples is measured at
room temperature.
Prior to the present invention, sterols were administered as a poorly
soluble crystalline solid. The present invention makes possible the solid
solution delivery of invention for treatment of hypercholesterolemia. The
present invention includes embodiments of oral solid dosage forms as
capsules, including semi-solid fills of the present invention in soft
capsules or hard-shell gelatin capsules; melt or extruded molded solid
tablets; and directly compressed tablets made from blends of the
sitosterol mixtures with standard tableting excipients. In addition, the
present invention can be included as semi-solid mixtures for inclusion in
foodstuffs. As used in this invention, semi-solid is understood to mean
highly viscous materials that do not flow easily. Generally semi-solid
materials have a viscosity of greater than about 5,000 centipoise, more
typically greater than about 10,000 centipoise.
A principal advantage of the present invention is the production of
sterol/stanol with improved dispersibility that minimizes the
incorporation of additional ingredients, i.e. surfactants, dispersants,
etc. Furthermore, since the hydrocarbon is added to the sterol/stanol as a
solid, and without the addition of water to form an emulsion, suspension
and the like, an expensive drying step is not required.
The present invention can also incorporate additional ingredients commonly
used for making a tablet. Among these items are excipients which is
understood to mean substance and materials used in the drug or food
industry which do not alter the character and function of the active
components of the aggregate. Flavors which may be optionally added are
well known to those in the art, including synthetic flavor oils, and/or
oils from plants, leaves flowers, fruits and so forth, and combinations
thereof. Representative flavor oils include spearmint, peppermint,
cinnamon, wintergreen, citrus oils, and fruit oils. Other suitable flavors
include caramel, bubble gum and the like. Flavorings are typically
employed at levels of from about 1 to about 5 weight percent.
Sweetening agents may also be employed such as monosaccharides,
disaccharides, and polysaccharides such as xylose, ribose, glucose,
mannose, galactose, fructose, dextrose, sucrose, maltose, corn syrup and
the like. Artificial agents may also be employed including saccharin,
cyclamates and acesulfam-K, aspartame, and the like. Sweeteners are
typically employed at levels of from about 1 to about 5 weight percent.
Dispersal agents include hydroxymethyl cellulose, corn starch,
croscarmellose cellulose (Ac-Di-Sol made by FMC Corp.) and mixtures
thereof. Dispersal agents may be incorporated from about 2 to about 20
weight percent.
Lubricants can also be added to the mixture to aid in the processing of
the tablets. These compounds are well known in the art, with magnesium
stearate being most preferred. Lubricants are typically employed at levels
of from about 1 to about 5 weight percent.
After the invention is ground to a powder it is packaged in any suitable
size as may be required. The form the invention is contained in may also
vary depending on the preference of the consumer. Suitable forms include
tablets, chewable dosages or applied to beverages and foodstuffs. In a
preferred embodiment, the invention may be packaged in single serving size
packets containing from about 5 to about 50 grams per packet.
Claim 1 of 20 Claims
What is claimed is:
1. A solid composition suitable to be orally administered comprising:
a sterol/stanol or sterol/stanol ester composition in an amount sufficient
to lower serum cholesterol;
a hydrocarbon selected from the group consisting of docusate sodium; mono,
di and tri glycerides, polyglocolized glycerides, mono-, and di-fatty
esters of polyethylene; acetylated monoglycerides; polyoxyl 40
hydrogenated castor oil; and polyoxyethylene 20 sorbitan monopalmitate;
said solid composition containing from about 0.4 to about 10 weight
percent hydrocarbon thereby providing a water dispersible mixture, the
solid composition free of water.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|